Basic Information
Basic information for DLGAP4-AS1-202-102aa
Peptide Name DLGAP4-AS1-202-102aa
Genome Position chr20:36512609-36512647,36525501-36525566,36525930-36526130[-]
Species Human
Peptide Sequence MDSCSRSQNPARSWAVGRGLASGFCGPDGDQWGQLSRGLSCSPQPPNKQGSSGPCQHPRGLLRPSVWGRNRSSWPWCDSDTERSPIHSQVSAHRSPGQGCPP
Peptide Length 102
Unique Yes
Grand Average of Hydropathicity -0.9863
Relative Molecular Mass 12772.53
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000232907;DLGAP4-AS1
Transcript ID/Name ENST00000433238;DLGAP4-AS1-202
Transcript Length 593
Coding Ability 0.6779
DNA Sequence Corresponding to Peptide ATGGACAGCTGTAGCAGGTCCCAGAACCCTGCCAGGTCCTGGGCTGTGGGGCGTGGGTTGGCATCAGGGTTCTGTGGGCCAGATGGGGATCAGTGGGGCCAGCTCAGCAGAGGCTTGTCCTGCTCCCCCCAACCCCCCAACAAGCAGGGTTCCTCTGGGCCCTGCCAGCACCCGCGGGGGCTCTTGAGGCCTAGTGTCTGGGGAAGAAACAGAAGTTCTTGGCCATGGTGTGACAGTGACACCGAGAGAAGCCCGATTCACTCCCAGGTTTCTGCTCACAGGTCACCTGGCCAGGGATGCCCTCCC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :